Meiji, Again, Halts Supply of Kobayashi Kako-Made Drugs after On-Site Inspections

December 23, 2020
Meiji Seika Pharma said on December 22 that it will temporarily stop the shipment of 13 APIs/43 products manufactured by Kobayashi Kako after health and prefectural authorities started on-site inspections into the partner’s manufacturing practices. Meiji had halted shipments to...read more